Benign breast tumors are a common clinical challenge. They often necessitate surgical intervention to address patient anxiety or physical discomfort. Selecting the most effective method for benign breast tumor surgery is critical for ensuring both clinical efficacy and patient satisfaction. Recently, ultrasound-guided Mammotome minimally invasive surgery has emerged as a prominent alternative to traditional open surgery.

Advantages of Minimally Invasive Benign Breast Tumor Surgery

A recent meta-analysis systematically evaluated the outcomes of 1,909 patients across eight studies published between 2018 and 2023. Consequently, researchers identified significant differences in several key surgical metrics. Most notably, the operation time for the Mammotome procedure was significantly shorter than traditional methods. Furthermore, patients undergoing the minimally invasive approach experienced less intraoperative bleeding and shorter hospital stays. Additionally, the length of surgical scars was markedly reduced. This reduction directly contributed to higher postoperative aesthetic satisfaction. Consequently, many surgeons now prefer this technique for small to medium-sized lesions.

Safety profiles also favored the minimally invasive group. In contrast to open surgery, which requires larger incisions, ultrasound-guided procedures minimize tissue trauma. Therefore, the incidence of postoperative complications, such as wound infections and hematomas, was lower in the Mammotome cohorts. Moreover, real-time ultrasound guidance ensures complete tumor excision while preserving healthy breast tissue.

Comparing Clinical Efficacy and Recovery

The pooled data demonstrated that the mean difference in operation time was substantial [MD = -12.79, 95%CI (-14.04, -11.55)]. This reduction in time improves theater efficiency. It also reduces the duration of anesthesia for the patient. Furthermore, the recovery period was faster. This allows patients to return to their daily activities much sooner. In summary, the Mammotome system provides an excellent balance between thorough tumor removal and superior cosmetic results.

FAQs

Is Mammotome surgery suitable for all benign breast tumors?

Typically, ultrasound-guided Mammotome surgery is most effective for benign lesions smaller than 3 cm. Larger tumors may still require traditional open surgery to ensure complete removal and clear margins.

What are the primary cosmetic benefits of this procedure?

Unlike open surgery, which leaves a visible linear scar, the Mammotome system uses a tiny puncture site. Therefore, the resulting scar is minimal and often fades significantly over time.

Does the minimally invasive approach increase the risk of recurrence?

Research indicates that when performed under precise ultrasound guidance, the complete excision rate is comparable to open surgery. Consequently, the risk of recurrence is not significantly higher for appropriately selected patients.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Liu X et al. Meta-Analysis of the Efficacy of Ultrasound-Guided Mammotome Minimally Invasive Surgery and Traditional Open Surgery in the Therapy of Benign Breast Tumors. Surg Innov. 2026 Mar 21. doi: 10.1177/15533506261433811. PMID: 41863150.

Ding B et al. Meta analysis of efficacy and safety between Mammotome vacuum-assisted breast biopsy and open excision for benign breast tumor. Gland Surg. 2013;2(2):69-79. doi:10.3978/j.issn.2227-684X.2013.05.06.